Repligen projects $813M-$834M 2026 revenue amid BioLife deal and raised $2.03-$2.09 EPS
Reported by Seeking Alpha · seekingalpha.com ·
Story context
What to watch: This report cites a concrete figure ($2.03) — compare it against the trailing trend before treating one data point as a turning point.
Latest session change: $RGEN +3.35%, $BLFS +0.00%
How this was labelled
Seeking Alpha published this one, and Wook filed it under Earnings. The automated reading is neutral, at low severity. Both of those labels come from matching words in the headline and preview against a fixed list. No editor and no AI is involved, which keeps them consistent and also keeps them blunt: they describe how the story is worded, not what it will do. It was matched to $RGEN and $BLFS, so the prices beside it cover 2 companies rather than one. Matching works by reading symbols and company names out of the text, which means a company mentioned in passing gets tagged the same way as the one the story is about. The headline or preview carried 4 figures — $813 million, $834 million, $2.03 and $2.09 — shown above exactly as published. Nothing was recalculated. The publisher gave no preview text for this story, so only the headline appears above. Nothing has been written in to fill the gap.
When it landed
This one landed while New York was open, so the move shown beside it is a move the market could have been making as the story went round. It is worth keeping the two apart: the price next to a story and the story itself run on different clocks. The publication time is whatever the publisher stamped on it. Weekends are taken into account here; market holidays are not.
Where the price is
$RGEN last traded at $184.17, +3.35% on the session. That is in the upper part of its 52-week range; the year runs $100.99 to $198.87. $BLFS last traded at $38.61, +0.00% on the session. That is within a tenth of its 52-week high; the year runs $17.86 to $39.76. These are the latest session quotes rather than live prices. A day's move picks up everything else that happened that day, so nothing here says this story caused any of it.
How much is being written
Wook has stored 1 story about these names in the last 30 days, 0 of them this week. None of it arrived in the last week, so the run has gone quiet. Across the whole run the wording has been close to balanced: 0% bullish, 100% neutral, 0% bearish. That is a count of how stories were worded, not what anyone thinks. Only this one came from Seeking Alpha, so the run is spread across outlets rather than driven by a single desk. 12 are listed beside this one if you want to follow the trail yourself.
What is already on the calendar
$RGEN earnings in 11 days and $BLFS earnings in 20 days. These are dates Wook already holds for the companies in this story. They are here because they are scheduled, not because this story has anything to do with them.
What this page is not saying
The tone and severity labels come from keyword matching. They are not a forecast, not a member vote, and not a recommendation. Any figures are copied from the headline or preview rather than worked out here, and a price move on the same day does not mean this story caused it. None of this is investment advice.
Discussion
No one has weighed in yet. Start the discussion on this story.
What happened after this published
Seeking Alpha published this on July 28, 2026. $RGEN has moved +30.40% ($141.23 to $184.17) and $BLFS has moved -0.00% ($38.61 to $38.61). Measured from the first print available after publication, against the latest available quote. This comparison does not isolate the story's effect.